Interaction of lipid nanoparticles with human epidermis and an organotypic cell culture model

International Journal of Pharmaceutics

Volumn 354, Issue 1-2, 2008, Pages 180-195

  Kuntsche, Judith ^a,b   Bunjes, Heike ^b,c   Fahr, Alfred ^b   Pappinen, Sari ^a   Rönkkö, Seppo ^a   Suhonen, Marjukka ^a   Urtti, Arto ^a,d  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

(Trans)dermal drug delivery; Colloidal drug carrier; Organotypic cell culture; Permeation; Stratum corneum thermal behavior

Indexed keywords

CORTICOSTERONE; FLUORESCENT DYE; LIPID; LIPID EMULSION; NANOPARTICLE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EPIDERMIS; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN PERMEABILITY; X RAY DIFFRACTION;

ADHESIONS; ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CELL CULTURE TECHNIQUES; CORTICOSTERONE; EPIDERMIS; FLUORESCENT DYES; HUMANS; KERATINOCYTES; LIPIDS; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; PARTICLE SIZE; PERMEABILITY; PHASE TRANSITION; RATS; SKIN ABSORPTION;

EID: 40849136115     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.08.028     Document Type: Article

References (60)

1. Al-Saidan S.M. Transdermal self-permeation enhancement of ibuprofen. J. Control. Rel. 100 (2004) 199-209
2. Al-Saidan S.M., Barry B.W., and Williams A.C. Differential scanning calorimetry of human and animal stratum corneum membranes. Int. J. Pharm. 168 (1998) 17-22
3. Alvarez-Román R., Naik A., Kalia Y.N., Guy R.H., and Fessi H. Skin penetration and distribution of polymeric nanoparticles. J. Control. Rel. 99 (2004) 53-62
4. Bender J., Ericson M.B., Merclin N., Iani V., Rosén A., Engström S., and Moan J. Lipid cubic phases for improved topical drug delivery in photodynamic therapy. J. Control. Rel. 106 (2005) 350-360
5. Bernard E., Dubois J.L., and Wepierre J. Importance of sebaceous glands in cutaneous penetration of an antiandrogen: target effect of liposomes. J. Pharm. Sci. 86 (1997) 573-578
6. Bouwstra J.A., Gooris G.S., Bras W., and Downing D.T. Lipid organization in pig stratum corneum. J. Lipid Res. 36 (1995) 685-695
7. Boyce S.T. Design principles for composition and performance of cultured skin substitutes. Burns 27 (2001) 523-533
8. Bunjes H., Westesen K., and Koch M.H.J. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int. J. Pharm. 129 (1996) 159-173
9. Bunjes H. Characterization of solid lipid nano- and microparticles. In: Nastruzzi C. (Ed). Lipospheres in Drug Targets and Delivery (2005), CRC Press, Boca Raton 41-66
10. Bunjes H., and Kuntsche J. Supercooled smectic nanoparticles. In: Thassu D., Deleers M., and Pathak Y. (Eds). Nanoparticulate Drug Delivery Systems (2007), Informa Health Care, New York 129-140
11. Cornwell P.A., Barry B.W., Bouwstra J.A., and Gooris G.S. Modes of action of terpene penetration enhancers in human skin; differential scanning calorimetry, small-angle X-ray diffraction and enhancer uptake studies. Int. J. Pharm. 127 (1996) 9-26
12. Dreher F., Fouchard F., Patouillet C., Andrian M., Simonnet J.T., and Benech-Kieffer F. Comparison of cutaneous bioavailability of cosmetic preparations containing caffeine or α-tocopherol applied on human skin models or human skin ex vivo at finite doses. Skin Pharmacol. Appl. Skin Physiol. 15 (2002) 40-58
13. Esposito E., Cortesi R., Drechsler M., Paccamiccio L., Mariani P., Contado C., Stellin E., Menegatti E., Bonina F., and Puglia C. Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm. Res. 22 (2005) 2163-2173
14. Friedmann D.I., Schwarz J.S., and Weisspapir M. Submicron emulsion vehicle for enhanced transdermal delivery of steroidal and nonsteroidal antiinflammatory drugs. J. Pharm. Sci. 84 (1995) 324-329
15. Gay C.L., Guy R.H., Golden G.M., Mak V.H.W., and Francoeur M.L. Characterization of low-temperature (i.e. <65 °C) lipid transitions in human stratum corneum. J. Invest. Dermatol. 103 (1994) 233-239
16. Golden G.M., Guzek D.B., Harris R.R., McKie J.E., and Potts R.O. Lipid thermotropic transitions in human stratum corneum. J. Invest. Dermatol. 86 (1986) 255-259
17. Greene R.S., Downing D.T., Pochi P.E., and Strauss J.S. Anatomical variation in the amount and composition of human skin surface lipid. J. Invest. Dermatol. 54 (1970) 240-247
18. Gustafsson J., Ljusberg-Wahren H., Almgren M., and Larsson K. Submicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer. Langmuir 13 (1997) 6964-6971
19. Gysler A., Kleuser B., Sippl W., Lange K., Korting H.C., Höltje H.D., and Schäfer-Korting M. Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin. Pharm. Res. 16 (1999) 1386-1391
20. Jenning V., Gysler A., Schäfer-Korting M., and Gohla S.H. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur. J. Pharm. Biopharm. 49 (2000) 211-218
21. Jenning V., Schäfer-Korting M., and Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J. Control. Rel. 66 (2000) 115-126
22. Jores K., Mehnert W., Drechsler M., Bunjes H., Johann C., and Mäder K. Investigations on the structure of solid lipid nanoparticles (SNL) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J. Control. Rel. 95 (2004) 217-227
23. Kirjavainen M., Urtti A., Jääskeläinen I., Suhonen T.M., Paronen P., Valjakka-Koskela R., Kiesvaara J., and Mönkkönen J. Interaction of liposomes with human skin in vitro-the influence of lipid composition and structure. Biochim. Biophys. Acta 1304 (1996) 179-189
24. Klang S., and Benita S. Design and evaluation of submicron emulsions as colloidal drug carriers for intravenous administration. In: Benita S. (Ed). Submicron Emulsions in Drug Targeting and Delivery (1998), Harwood Academic Publ., Amsterdam 119-152
25. Kuntsche J., Westesen K., Drechsler M., Koch M.H.J., and Bunjes H. Supercooled smectic nanoparticles: a potential novel carrier system for poorly water soluble drugs. Pharm. Res. 21 (2004) 1834-1843
26. Lombardi Borgia S., Regehly M., Sivaramakrishnan R., Mehnert W., Korting H.C., Danker K., Röder B., Kramer K.D., and Schäfer-Korting M. Lipid nanoparticles for skin penetration enhancement - correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J. Control. Rel. 110 (2005) 151-163
27. Lopes L.B., Collett J.H., and Bentley M.V. Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer. Eur. J. Pharm. Biopharm. 60 (2005) 25-30
28. Mehnert W., and Mäder K. Solid lipid nanoparticles-production, characterization and applications. Adv. Drug Del. Rev. 47 (2001) 165-196
29. Mei Z., Chen H., Weng T., Yang Y., and Yang X. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur. J. Pharm. Biopharm. 56 (2003) 189-196
30. Mei Z., Wu Q., Hu S., Li X., and Yang X. Triptolide loaded solid lipid nanoparticle hydrogel for topical application. Drug Dev. Ind. Pharm. 31 (2005) 161-168
31. Meidan V.M., Bonner M.C., and Michniak B.B. Transfollicular drug delivery-Is it a reality?. Int. J. Pharm. 306 (2005) 1-14
32. Müller R.H., Mäder K., and Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur. J. Pharm. Biopharm. 50 (2000) 161-177
33. Müller R.H., Radtke M., and Wissing S.A. Nanostructured lipid matrices for improved microencapsulation of drugs. Int. J. Pharm. 242 (2002) 121-128
34. Müller R.H., Radtke M., and Wissing S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Del. Rev. 54 (2002) S131-S155
35. Münster U., Nakamura C., Haberland A., Jores K., Mehnert W., Rummel S., Schaller M., Korting H.C., Zouboulis Ch.C., Blume-Peytavi U., and Schäfer-Korting M. RU 58841-myristate - prodrug development for topical treatment of acne and androgenetic alopecia. Pharmzie 60 (2005) 8-12
36. Netzlaff F., Kostka K.H., Lehr C.M., and Schaefer U.F. TEWL measurements as a routine method for evaluating the integrity of epidermis sheets in static Franz type diffusion cells in vitro. Limitations shown by transport data testing. Eur. J. Pharm. Biopharm. 63 (2006) 44-50
37. ® in comparison to various human skin preparations. Eur. J. Pharm. Biopharm. 66 (2007) 127-134
38. Nuutinen J., Alanen E., Autio P., Lahtinen M.R., Harvima I., and Lahtinen T. A closed unventilated chamber for the measurement of transepidermal water loss. Skin Res. Technol. 9 (2003) 85-89
39. OECD, Guidance document for the conduct of skin absorption studies, Number 28, 2004, OECD series on testing and assessment.
40. Pappinen S., Pasonen-Seppänen S., Suhonen M., Tammi R., and Urtti A. Rat epidermal keratinocyte organotypic culture (ROC) as a model for chemically induced skin irritation testing. Toxicol. Appl. Pharmacol. 208 (2005) 233-241
41. Pasonen-Seppänen S., Suhonen T.M., Kirjavainen M., Miettinen M., Urtti A., Tammi M., and Tammi R. Formation of permeability barrier in epidermal organotypic culture for studies on drug transport. J. Invest. Dermatol. 117 (2001) 1322-1324
42. Pasonen-Seppänen S., Suhonen T.M., Kirjavainen M., Suihko E., Urtti A., Miettinen M., Hyttinen M., Tammi M., and Tammi R. Vitamin C enhances differentiation of a continuous keratinocyte cell line (REK) into epidermis with normal stratum corneum ultrastructure and functional permeability barrier. Histochem. Cell Biol. 116 (2001) 287-297
43. Ponec M. Skin constructs for replacement of skin tissues for in vitro testing. Adv. Drug Del. Rev. 54 (2002) S19-S30
44. Santos Maia C., Mehnert W., Schaller M., Korting H.C., Gysler A., Haberland A., and Schäfer-Korting M. Drug targeting by solid lipid nanoparticles for dermal use. J. Drug Targ. 10 (2002) 489-495
45. Schaefer H., and Redelmeier T. Skin Barrier. Principles of Percutaneous Absorption (1996), Karger Basel pp. 43-86, chapter 2
46. Schreiber S., Mahmoud A., Vuia A., Rübbelke M.K., Schmidt E., Schaller M., Kandárová H., Haberland A., Schäfer U.F., Bock U., Korting H.C., Liebsch M., and Schäfer-Korting M. Reconstructed epidermis versus human and animal skin in skin absorption studies. Toxicol. in Vitro 19 (2005) 813-822
47. Schwarz J.S., Weisspapir M.R., and Friedmann D.I. Enhanced transdermal delivery of diazepam by submicron emulsion (SME) creams. Pharm. Res. 12 (1995) 687-692
48. Sivaramakrishnan R., Nakamura C., Mehnert W., Korting H.C., Kramer K.D., and Schäfer-Korting M. Glucocorticoid entrapment into lipid carriers - characterization by parelectric spectroscopy and influence on dermal uptake. J. Control. Rel. 97 (2004) 493-502
49. Specht Ch., Stoye I., and Müller-Goymann C.C. Comparative investigations to evaluate the use of organotypic cultures of transformed and native dermal and epidermal cells for permeation studies. Eur. J. Pharm. Biopharm. 46 (1998) 273-278
50. Suhonen T.M., Pasonen-Seppänen S., Kirjavainen M., Tammi M., Tammi R., and Urtti A. Epidermal cell culture model derived from rat keratinocytes with permeability characteristics comparable to human cadaver skin. Eur. J. Pharm. Sci. 20 (2003) 107-113
51. Üner M., Wissing S.A., Yener G., and Müller R.H. Skin moisturizing effect and skin penetration of ascorbyl palmitate entrapped in solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) incorporated into hydrogel. Pharmazie 60 (2005) 751-755
52. Unruh T., Bunjes H., Westesen K., and Koch M.H.J. Investigations on the melting behavior of triglyceride nanoparticles. Colloid Polym. Sci. 279 (2001) 398-403
53. Van Duzee B.F. Thermal analysis of human stratum corneum. J. Invest. Dermatol. 65 (1975) 404-408
54. Washington C. Evaluation of non-sink dialysis methods for the measurement of drug release from colloids: effects of drug partition. Int. J. Pharm. 56 (1989) 71-74
55. Wertz P.W., Abraham W., Landmann L., and Downing D.T. Preparation of liposomes from stratum corneum lipids. J. Invest. Dermatol. 87 (1986) 582-584
56. Westesen K. Novel lipid-based colloidal dispersions as potential drug administration systems - expectations and reality. Colloid. Polym. Sci. 278 (2000) 608-618
57. Wissing S.A., and Müller R.H. The development of an improved carrier system for sunscreen formulations based on crystalline lipid nanoparticles. Int. J. Pharm. 242 (2002) 373-375
58. Wissing S.A., and Müller R.H. Cosmetic applications for solid lipid nanoparticles (SLN). Int. J. Pharm. 254 (2003) 65-68
59. Wissing S.A., and Müller R.H. The influence of solid lipid nanoparticles on skin hydration and viscoelasticity - in vivo study. Eur. J. Pharm. Biopharm. 56 (2003) 67-72
60. Wörle G., Siekmann B., Koch M.H.J., and Bunjes H. Transformation of vesicular into cubic nanoparticles by autoclaving of aqueous monoolein/poloxamer dispersions. Eur. J. Pharm. Sci. 27 (2006) 44-53